Azelaprag
(2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methyl-3-pyridinyl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide
Molecular Identity
Azelaprag
(2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methyl-3-pyridinyl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide
PubChem CID: 122702529
2D Structure
Properties
C25H29N7O4S
Molecular Formula
523.60
Molecular Weight
g/mol
523.2002
Exact Mass
Da
2.7
XLogP
Drug-like (Lipinski: < 5)
142
TPSA
May have limited oral absorption
1
H-Bond Donors
10
H-Bond Acceptors
810
Complexity
SMILES
Canonical SMILES
SMILES: CC1=CC(=CN=C1)C2=NN=C(N2C3=C(C=CC=C3OC)OC)NS(=O)(=O)C(C)C(C)C4=NC=C(C=N4)CIsomeric SMILES
SMILES: CC1=CC(=CN=C1)C2=NN=C(N2C3=C(C=CC=C3OC)OC)NS(=O)(=O)[C@@H](C)[C@H](C)C4=NC=C(C=N4)CSynonyms(20)
AzelapragAzelaprag [INN]4B8REJ8ZGYAMG986AMG 986UNII-4B8REJ8ZGYAMG-986example 263 [WO2016187308A1](2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide2-Pyrimidineethanesulfonamide, N-(4-(2,6-dimethoxyphenyl)-5-(5-methyl-3-pyridinyl)-4H-1,2,4-triazol-3-yl)-alpha,beta,5-trimethyl-, (alphaS,betaR)-2-PYRIMIDINEETHANESULFONAMIDE, N-(4-(2,6-DIMETHOXYPHENYL)-5-(5-METHYL-3-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL)-.ALPHA.,.BETA.,5-TRIMETHYL-, (.ALPHA.S,.BETA.R)-example 263 (WO2016187308A1)azelapragum(2S,3R)-N-(4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl)-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamideRefChem:116069
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Azelaprag
Loading drug network...